2 Green Flags for Pfizer's Future

Will pharma giant Pfizer (NYSE: PFE) run out of steam? The company's shares have soundly outperformed the market in the past year, mainly due to its COVID-19 vaccine, Comirnaty, which it developed in collaboration with BioNTech. However, investors may worry that once Pfizer's coronavirus tailwind comes to a halt, the company will see much darker days.

This could put downward pressure on the company's shares. While that's a legitimate worry, there are excellent reasons to be optimistic about Pfizer's future. Here are just two of them.

Continue reading

Source Fool.com